NCT01381445View on ClinicalTrials.gov

A Study Assessing GW870086's Potential to Cause Skin Thinning

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 14, 2011

Primary Completion Date

July 7, 2011

Study Completion Date

July 7, 2011

Conditions
Dermatitis, Atopic
Interventions
DRUG

GW870086 0.2%

White to slightly coloured opaque cream

DRUG

GW870086 2%

White to slightly coloured opaque cream

DRUG

Clobetasol Propionate

White cream

DRUG

Placebo

White to slightly coloured opaque cream

Trial Locations (1)

10117

GSK Investigational Site, Berlin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01381445 - A Study Assessing GW870086's Potential to Cause Skin Thinning | Biotech Hunter | Biotech Hunter